# Biocryst Pharmaceuticals Inc: Form 8-K, filed Aug 11, 2025

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K
- Filed: 2025-08-11
- Accepted by EDGAR: Aug 11, 2025, 07:10 ET
- Period: 2025-08-11
- Accession: 0001171843-25-005265
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184325005265/f8k_081125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184325005265/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184325005265/f8k_081125.htm

Filed Aug 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-005265. Last ingested by Listed: Nov 4, 2026, 16:44 ET. No prices; not investment advice.